磷酸二酯酶-5抑制剂有望改善COPD肺动脉高压患者的生存：又向前迈进了一步，但仍有很长的路要走

IF 9.5 1区医学 Q1 CRITICAL CARE MEDICINE Chest Pub Date : 2025-01-01 DOI:10.1016/j.chest.2024.10.014

Ari Chaouat, Simon Valentin, Yochai Adir

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Phosphodiesterase-5 Inhibitors Show Promise in Improving Survival for Patients With COPD Pulmonary Hypertension: One Step Further But There Is Still a Long Way to Go.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Chest 医学-呼吸系统

CiteScore

13.70

自引率

3.10%

发文量

3369

审稿时长

15 days

期刊介绍： At CHEST, our mission is to revolutionize patient care through the collaboration of multidisciplinary clinicians in the fields of pulmonary, critical care, and sleep medicine. We achieve this by publishing cutting-edge clinical research that addresses current challenges and brings forth future advancements. To enhance understanding in a rapidly evolving field, CHEST also features review articles, commentaries, and facilitates discussions on emerging controversies. We place great emphasis on scientific rigor, employing a rigorous peer review process, and ensuring all accepted content is published online within two weeks.

期刊最新文献

Modified Cuff Leak Test for Predicting the Risk of Reintubation in Patients with Invasive Mechanical Ventilation: A Multicenter, Single-Blind, Randomized Controlled Trial. Trajectories of interferon-gamma release assay results over two years in independent cohorts from China, South Africa, Tanzania, and the United States. Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS. Hermansky-Pudlak Syndrome in the United States. How I Do It: Communicating to Patients and Families about Post Intensive Care Syndrome.